Skip to main content
Erschienen in: Medical Oncology 2/2015

01.02.2015 | Original Paper

CCR7 pathway induces epithelial–mesenchymal transition through up-regulation of Snail signaling in gastric cancer

verfasst von: Jianping Zhang, Yunzhe Zhou, Yonggang Yang

Erschienen in: Medical Oncology | Ausgabe 2/2015

Einloggen, um Zugang zu erhalten

Abstract

The chemokine receptor 7 (CCR7) and Snail signaling have been linked to various types of cancers. The associations between these signalings and the epithelial–mesenchymal transition (EMT) are not clear in gastric cancer. Here, the expression of CCR7 and Snail was detected in gastric cancer by immunohistochemistry and Western blot. Meanwhile, gastric cancer cells were subjected to CCL19, si-control, and si-Snail treatment. Cell cycle, migration, and invasion were also analyzed. The expression patterns of CCR7 and Snail were similar in either gastric cancer tissues or cells. The increased expression of CCR7 was closely associated with the increased Snail expression, which both were closely correlated with metastasis, stage and differentiation, and poor prognosis. The increased p-ERK, p-AKT, Snail, and MMP9 expression and the decreased E-cadherin were confirmed in MGC803 cells in a dose-dependent manner in response to CCL19 treatment. However, the blockade of Snail abrogated the up-regulation of MMP9 and down-regulation of E-cadherin. CCR7-induced ERK and PI3K pathway regulated Snail signaling. Besides si-Snail treatment led to MGC803 cell cycle arrest and affected the migration and invasion. In conclusion, our study suggested that CCR7 promotes Snail expression to induce the EMT, resulting in cell cycle progression, migration, and invasion in gastric cancer. CCR7–Snail pathway provided more potential regimens for cancer therapy.
Literatur
1.
Zurück zum Zitat Assaraf YG, Leamon CP, Reddy JA. The folate receptor as a rational therapeutic target for personalized cancer treatment. Drug Resist Updat. 2014;17:89–95.PubMedCrossRef Assaraf YG, Leamon CP, Reddy JA. The folate receptor as a rational therapeutic target for personalized cancer treatment. Drug Resist Updat. 2014;17:89–95.PubMedCrossRef
2.
Zurück zum Zitat Lianos GD, Rausei S, Ruspi L, et al. Laparoscopic gastrectomy for gastric cancer: current evidences. Int J Surg. 2014;12:1369–73.PubMedCrossRef Lianos GD, Rausei S, Ruspi L, et al. Laparoscopic gastrectomy for gastric cancer: current evidences. Int J Surg. 2014;12:1369–73.PubMedCrossRef
4.
Zurück zum Zitat Velho S, Fernandes MS, Leite M, et al. Causes and consequences of microsatellite instability in gastric carcinogenesis. World J Gastroenterol. 2014;20:16433–42.PubMedCentralPubMedCrossRef Velho S, Fernandes MS, Leite M, et al. Causes and consequences of microsatellite instability in gastric carcinogenesis. World J Gastroenterol. 2014;20:16433–42.PubMedCentralPubMedCrossRef
5.
Zurück zum Zitat Rhee KH, Park JS, Cho MJ. Helicobacter pylori: bacterial strategy for incipient stage and persistent colonization in human gastric niches. Yonsei Med J. 2014;55:1453–66.PubMedCentralPubMedCrossRef Rhee KH, Park JS, Cho MJ. Helicobacter pylori: bacterial strategy for incipient stage and persistent colonization in human gastric niches. Yonsei Med J. 2014;55:1453–66.PubMedCentralPubMedCrossRef
7.
Zurück zum Zitat Lee JK, Joo KM, Lee J, et al. Targeting the epithelial to mesenchymal transition in glioblastoma: the emerging role of MET signaling. Onco Targets Ther. 2014;7:1933–44.PubMedCentralPubMed Lee JK, Joo KM, Lee J, et al. Targeting the epithelial to mesenchymal transition in glioblastoma: the emerging role of MET signaling. Onco Targets Ther. 2014;7:1933–44.PubMedCentralPubMed
8.
Zurück zum Zitat Steinestel K, Eder S, Schrader AJ, et al. Clinical significance of epithelial–mesenchymal transition. Clin Transl Med. 2014;2(3):17.CrossRef Steinestel K, Eder S, Schrader AJ, et al. Clinical significance of epithelial–mesenchymal transition. Clin Transl Med. 2014;2(3):17.CrossRef
9.
10.
Zurück zum Zitat Pang L, Li Q, Wei C, et al. TGF-β1/Smad signaling pathway regulates epithelial-to-mesenchymal transition in esophageal squamous cell carcinoma. in vitro and clinical analyses of cell lines and nomadic Kazakh patients from Northwest Xinjiang, China. PLoS One. 2014;9:e112300.PubMedCentralPubMedCrossRef Pang L, Li Q, Wei C, et al. TGF-β1/Smad signaling pathway regulates epithelial-to-mesenchymal transition in esophageal squamous cell carcinoma. in vitro and clinical analyses of cell lines and nomadic Kazakh patients from Northwest Xinjiang, China. PLoS One. 2014;9:e112300.PubMedCentralPubMedCrossRef
12.
13.
Zurück zum Zitat Legler DF, Uetz-von Allmen E, Hauser MA. CCR7: roles in cancer cell dissemination, migration and metastasis formation. Int J Biochem Cell Biol. 2014;54:78–82.PubMedCrossRef Legler DF, Uetz-von Allmen E, Hauser MA. CCR7: roles in cancer cell dissemination, migration and metastasis formation. Int J Biochem Cell Biol. 2014;54:78–82.PubMedCrossRef
14.
Zurück zum Zitat Somovilla-Crespo B, Alfonso-Pérez M, Cuesta-Mateos C, et al. Anti-CCR7 therapy exerts a potent anti-tumor activity in a xenograft model of human mantle cell lymphoma. J Hematol Oncol. 2013;6:89.PubMedCentralPubMedCrossRef Somovilla-Crespo B, Alfonso-Pérez M, Cuesta-Mateos C, et al. Anti-CCR7 therapy exerts a potent anti-tumor activity in a xenograft model of human mantle cell lymphoma. J Hematol Oncol. 2013;6:89.PubMedCentralPubMedCrossRef
15.
Zurück zum Zitat Liu FY, Safdar J, Li ZN, et al. CCR7 regulates cell migration and invasion through JAK2/STAT3 in metastatic squamous cell carcinoma of the head and neck. Biomed Res Int. 2014;2014:415375.PubMedCentralPubMed Liu FY, Safdar J, Li ZN, et al. CCR7 regulates cell migration and invasion through JAK2/STAT3 in metastatic squamous cell carcinoma of the head and neck. Biomed Res Int. 2014;2014:415375.PubMedCentralPubMed
16.
Zurück zum Zitat Liu Y, Ji R, Li J, et al. Correlation effect of EGFR and CXCR4 and CCR7 chemokine receptors in predicting breast cancer metastasis and prognosis. J Exp Clin Cancer Res. 2010;29:16.PubMedCentralPubMedCrossRef Liu Y, Ji R, Li J, et al. Correlation effect of EGFR and CXCR4 and CCR7 chemokine receptors in predicting breast cancer metastasis and prognosis. J Exp Clin Cancer Res. 2010;29:16.PubMedCentralPubMedCrossRef
17.
Zurück zum Zitat Arigami T, Natsugoe S, Uenosono Y, et al. CCR7 and CXCR4 expression predicts lymph node status including micrometastasis in gastric cancer. Int J Oncol. 2000;35:19–24. Arigami T, Natsugoe S, Uenosono Y, et al. CCR7 and CXCR4 expression predicts lymph node status including micrometastasis in gastric cancer. Int J Oncol. 2000;35:19–24.
18.
Zurück zum Zitat Li Y, Qiu X, Zhang S, et al. Hypoxia induced CCR7 expression via HIF-1alpha and HIF-2alpha correlates with migration and invasion in lung cancer cells. Cancer Biol Ther. 2009;8:322–30.PubMedCrossRef Li Y, Qiu X, Zhang S, et al. Hypoxia induced CCR7 expression via HIF-1alpha and HIF-2alpha correlates with migration and invasion in lung cancer cells. Cancer Biol Ther. 2009;8:322–30.PubMedCrossRef
19.
Zurück zum Zitat Kodama J, Hasengaowa, Seki N, et al. Expression of the CXCR4 and CCR7 chemokine receptors in human endometrial cancer. Eur J Gynaecol Oncol. 2007;28:370–5.PubMed Kodama J, Hasengaowa, Seki N, et al. Expression of the CXCR4 and CCR7 chemokine receptors in human endometrial cancer. Eur J Gynaecol Oncol. 2007;28:370–5.PubMed
20.
Zurück zum Zitat Katoh M. Epithelial–mesenchymal transition in gastric cancer (review). Int J Oncol. 2005;27:1677–83.PubMed Katoh M. Epithelial–mesenchymal transition in gastric cancer (review). Int J Oncol. 2005;27:1677–83.PubMed
21.
Zurück zum Zitat Shi Y, Wu H, Zhang M, et al. Expression of the epithelial–mesenchymal transition-related proteins and their clinical significance in lung adenocarcinoma. Diagn Pathol. 2013;8:89.PubMedCentralPubMedCrossRef Shi Y, Wu H, Zhang M, et al. Expression of the epithelial–mesenchymal transition-related proteins and their clinical significance in lung adenocarcinoma. Diagn Pathol. 2013;8:89.PubMedCentralPubMedCrossRef
22.
Zurück zum Zitat Shih JY, Yang PC. The EMT regulator slug and lung carcinogenesis. Carcinogenesis. 2011;32:1299–304.PubMedCrossRef Shih JY, Yang PC. The EMT regulator slug and lung carcinogenesis. Carcinogenesis. 2011;32:1299–304.PubMedCrossRef
23.
Zurück zum Zitat Jordan NV, Johnson GL, Abell AN. Tracking the intermediate stages of epithelial–mesenchymal transition in epithelial stem cells and cancer. Cell Cycle. 2011;10:2865–73.PubMedCentralPubMedCrossRef Jordan NV, Johnson GL, Abell AN. Tracking the intermediate stages of epithelial–mesenchymal transition in epithelial stem cells and cancer. Cell Cycle. 2011;10:2865–73.PubMedCentralPubMedCrossRef
24.
Zurück zum Zitat Yilmaz M, Christofori G. EMT, the cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev. 2009;28:15–33.PubMedCrossRef Yilmaz M, Christofori G. EMT, the cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev. 2009;28:15–33.PubMedCrossRef
25.
Zurück zum Zitat Hsu YL, Hou MF, Kuo PL, et al. Breast tumor-associated osteoblast-derived CXCL5 increases cancer progression by ERK/MSK1/Elk-1/snail signaling pathway. Oncogene. 2013;32:4436–47.PubMedCrossRef Hsu YL, Hou MF, Kuo PL, et al. Breast tumor-associated osteoblast-derived CXCL5 increases cancer progression by ERK/MSK1/Elk-1/snail signaling pathway. Oncogene. 2013;32:4436–47.PubMedCrossRef
26.
Zurück zum Zitat Jiang Y, Zhao X, Xiao Q, et al. Snail and Slug mediate tamoxifen resistance in breast cancer cells through activation of EGFR–ERK independent of epithelial–mesenchymal transition. J Mol Cell Biol. 2014;6:352–4.PubMedCrossRef Jiang Y, Zhao X, Xiao Q, et al. Snail and Slug mediate tamoxifen resistance in breast cancer cells through activation of EGFR–ERK independent of epithelial–mesenchymal transition. J Mol Cell Biol. 2014;6:352–4.PubMedCrossRef
27.
Zurück zum Zitat Chen KC, Chen CY, Lin CR, et al. Luteolin attenuates TGF-β1-induced epithelial–mesenchymal transition of lung cancer cells by interfering in the PI3K/Akt-NF-κB-Snail pathway. Life Sci. 2013;93:924–33.PubMedCrossRef Chen KC, Chen CY, Lin CR, et al. Luteolin attenuates TGF-β1-induced epithelial–mesenchymal transition of lung cancer cells by interfering in the PI3K/Akt-NF-κB-Snail pathway. Life Sci. 2013;93:924–33.PubMedCrossRef
28.
Zurück zum Zitat Zhang B, Yin C, Li H, et al. Nir1 promotes invasion of breast cancer cells by binding to chemokine (C–C motif) ligand 18 through the PI3K/Akt/GSK3β/Snail signalling pathway. Eur J Cancer. 2013;49:3900–13.PubMedCrossRef Zhang B, Yin C, Li H, et al. Nir1 promotes invasion of breast cancer cells by binding to chemokine (C–C motif) ligand 18 through the PI3K/Akt/GSK3β/Snail signalling pathway. Eur J Cancer. 2013;49:3900–13.PubMedCrossRef
29.
Zurück zum Zitat Myung JK, Choi SA, Kim SK, et al. Snail plays an oncogenic role in glioblastoma by promoting epithelial mesenchymal transition. Int J Clin Exp Pathol. 2014;7:1977–87.PubMedCentralPubMed Myung JK, Choi SA, Kim SK, et al. Snail plays an oncogenic role in glioblastoma by promoting epithelial mesenchymal transition. Int J Clin Exp Pathol. 2014;7:1977–87.PubMedCentralPubMed
30.
Zurück zum Zitat Liu ZC, Chen XH, Song HX, et al. Snail regulated by PKC/GSK-3β pathway is crucial for EGF-induced epithelial–mesenchymal transition (EMT) of cancer cells. Cell Tissue Res. 2014;358:491–502.PubMedCrossRef Liu ZC, Chen XH, Song HX, et al. Snail regulated by PKC/GSK-3β pathway is crucial for EGF-induced epithelial–mesenchymal transition (EMT) of cancer cells. Cell Tissue Res. 2014;358:491–502.PubMedCrossRef
31.
Zurück zum Zitat Liu ZC, Wang HS, Zhang G, et al. AKT/GSK-3β regulates stability and transcription of snail which is crucial for bFGF-induced epithelial–mesenchymal transition of prostate cancer cells. Biochim Biophys Acta. 2014;1840:3096–105.PubMedCrossRef Liu ZC, Wang HS, Zhang G, et al. AKT/GSK-3β regulates stability and transcription of snail which is crucial for bFGF-induced epithelial–mesenchymal transition of prostate cancer cells. Biochim Biophys Acta. 2014;1840:3096–105.PubMedCrossRef
Metadaten
Titel
CCR7 pathway induces epithelial–mesenchymal transition through up-regulation of Snail signaling in gastric cancer
verfasst von
Jianping Zhang
Yunzhe Zhou
Yonggang Yang
Publikationsdatum
01.02.2015
Verlag
Springer US
Erschienen in
Medical Oncology / Ausgabe 2/2015
Print ISSN: 1357-0560
Elektronische ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-014-0467-9

Weitere Artikel der Ausgabe 2/2015

Medical Oncology 2/2015 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.